XML 30 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITIES
12 Months Ended
Sep. 30, 2022
DERIVATIVE LIABILITIES  
DERIVATIVE LIABILITIES

8.     DERIVATIVE LIABILITIES

In January 2016, the Company completed a private placement of 227,273 units of the Company at $66.00 per unit (“Unit”) for gross proceeds of $14,999,992. Each Unit consisted of one common share of the Company, one 7-year cash and cashless exercise warrant (the “7-Year Warrants”), and one half of one 2-year cash exercise warrant (the “2-Year Warrants”). The 7-Year Warrants and 2-Year Warrants have an exercise price of $66.00 per common share (collectively, the “2016 Warrants”). The holders of the 7-Year Warrants may elect, in lieu of exercising the 7-Year Warrants for cash, a cashless exercise option, in whole or in part, to receive common shares equal to the fair value of the 7-Year Warrants based on the number of 7-Year Warrants to be exercised multiplied by a ten-day weighted average market price less the exercise price with the difference divided by the weighted average market price. If a warrant holder exercises this option, there will be variability in the number of shares issued per 7-Year Warrant.

Additionally, the 2016 Warrants contain provisions which may require the Company to redeem the 2016 Warrants, at the option of the holder, in the event of a major transaction, such as a change of control or sale of the Company’s assets (“Major Transaction”). The redemption value would be subject to a Black-Scholes valuation at the time of exercise. In the event the consideration for a Major Transaction payable to the common shareholders is in cash, in whole or in part, the redemption of the 2016 Warrants would be made in cash pro-rata to the composition of the consideration. The potential for a cash settlement for the 2016 Warrants outside the control of the Company, in accordance with U.S. GAAP, requires the 2016 Warrants to be treated as financial liabilities measured at fair value through profit or loss. The 2016 Warrants are not traded in an active market.

Valuation

The Company uses the Black-Scholes option pricing model to estimate fair value. The following weighted average assumptions were used to estimate the fair value of the derivative warrant liabilities on September 30, 2022 and 2021:

September 30, 

September 30, 

2022

    

2021

Risk-free interest rate

 

3.55

%  

0.49

%

Expected life

 

0.28

years

1.28

years

Expected annualized volatility

 

73.3

%  

86.0

%

Dividend

 

 

Liquidity discount

 

20

%  

20

%

The following table is a continuity schedule of changes to the Company’s derivative liabilities:

    

Total

Balance, September 30, 2020

 

$

127,376

Change in fair value

 

(107,024)

Balance, September 30, 2021

 

$

20,352

Change in fair value

 

(20,352)

Balance, September 30, 2022

 

$